Anti-human Amyloid Beta (U.Zurich patent Anti-Amyloid Beta Biosimilar) Size:1 mg If the positive signal is

If the positive signal is weak

: IHC0110R

regulatory domains

CD44 is expressed by hematopoietic

This isozyme preferentially utilizes arachidonate as substrate

Anti-human Amyloid Beta (U.Zurich patent Anti-Amyloid Beta Biosimilar) Size:1 mg If the positive signal isApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name Amyloid Beta Target Uniprot P05067 Overview Catalog# BIO0813SM Product Name Anti human Amyloid Beta (U. Zurich patent Anti Amyloid Beta Biosimilar) Specifications Conjugation None Clone# U. Zurich patent Anti Amyloid Beta Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower.